Position in DHR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$209,718
+$969 QoQ
Shares Held
1,101
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,754
of 2,098 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026STALEY CAPITAL ADVISERS INC holds $486,468 across 2 Diagnostics & Research names. DHR ranks #2 (43.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
552 | $276,750 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
1,101 | $209,718 |
All Filings in DHR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,718 | 1,101 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $208,749 | 1,101 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $252,040 | 1,101 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $218,284 | 1,101 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $217,491 | 1,101 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $225,705 | 1,101 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $252,734 | 1,101 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $306,100 | 1,101 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $275,084 | 1,101 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $274,941 | 1,101 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $254,705 | 1,101 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $273,158 | 1,101 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $273,600 | 1,140 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $285,309 | 1,132 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||